Skip to content
Search for:
HOME
ABOUT ACHIEVE
About Us
Management Team
Board of Directors
Careers
PRODUCTS
Cytisinicline
Phase 3 ORCA-2 Trial
Phase 2 ORCA-1 Trial
NEWS
Press Releases
Events
Blog
INVESTORS
CONTACT
Loading...
Clinical Trials
Home
/
Clinical Trials
Clinical Trials
ivps4
2020-09-21T19:16:04-05:00
Positive Phase 2b ORCA-1 Results Reported
Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial